Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice.
暂无分享,去创建一个
M. Fowler | É. Mercier | K. D. de Cock | I. de Vincenzi | J. Saba | E. Hoff | D. Alnwick | M. Rogers | N. Shaffer | K M De Cock | M G Fowler | E Mercier | I de Vincenzi | J Saba | E Hoff | D J Alnwick | M Rogers | N Shaffer | M. Rogers | K. M. Cock | E. Hoff | I. Vincenzi | E. Mercier
[1] S. Gortmaker,et al. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. , 1999, JAMA.
[2] J. Curran,et al. Science, ethics, and future of research into maternal-infant transmission of HIV-1 , 1999, The Lancet.
[3] D. Harris,et al. RISK FACTORS FOR PERINATAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 IN WOMEN TREATED WITH ZIDOVUDINE , 1999 .
[4] J. Goedert,et al. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission , 1996, The Lancet.
[5] M. Kalish,et al. Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group. , 1999, AIDS.
[6] Europeancollaborativestudy. Risk factors for mother-to-child transmission of HIV-1. , 1992, Lancet.
[7] D. Wara,et al. Proposed definitions for in utero versus intrapartum transmission of HIV-1. , 1992, The New England journal of medicine.
[8] K. Holmes,et al. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world. , 1996, The American journal of tropical medicine and hygiene.
[9] E. Cheraskin. Mother–infant HIV transmission: Making the most of what we know , 1996, Nature Network Boston.
[10] B. Hirschel,et al. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects , 1998, AIDS.
[11] R. Biggar,et al. Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in malawi: clinical trial , 1997, BMJ.
[12] S. Spector,et al. Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team. , 1998, The Journal of infectious diseases.
[13] P. Rustin,et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues , 1999, The Lancet.
[14] P. Lurie,et al. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. , 1997, The New England journal of medicine.
[15] L. Rodrigues,et al. Late postnatal mother-to-child transmission of HIV-1 , 1998, The Lancet.
[16] R. Biggar,et al. HIV transmission through breastfeeding: a study in Malawi. , 1999, JAMA.
[17] C. Giaquinto,et al. Risk factors for mother‐to‐child transmission of HIV‐1 , 1992 .
[18] L. Sokoll,et al. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. , 1999, The Journal of infectious diseases.
[19] J. Karon,et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial , 1999, The Lancet.
[20] L. Kuhn,et al. Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study. South African Vitamin A Study Group. , 1999, Lancet.
[21] Dorothy Bray,et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial , 1999, The Lancet.
[22] T. Quinn,et al. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire. , 1996, The Journal of infectious diseases.
[23] L. Mofenson. Mother-child HIV-1 transmission: Timing and determinants. , 1997, Obstetrics and gynecology clinics of North America.
[24] R. Salamon,et al. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial , 1999, The Lancet.
[25] F. Onyango,et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. , 2000, JAMA.
[26] F. Dabis,et al. Cost‐effectiveness and cost‐benefit in the prevention of mother‐to‐child transmission of HIV in developing countries , 1998 .
[27] E. Karita,et al. An assessment of the timing of mother-to-child transmission of human immunodeficiency virus type 1 by means of polymerase chain reaction. , 1994, Journal of acquired immune deficiency syndromes.
[28] E. Karita,et al. Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda. , 1991, The New England journal of medicine.
[29] Ijsselmuiden Cb. Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World. , 1998 .
[30] A. Ades,et al. Risk of human immunodeficiency virus type 1 transmission through breastfeeding , 1992, The Lancet.
[31] L. Kalish,et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. , 1999, The New England journal of medicine.
[32] Elliot Marseille,et al. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa , 1999, The Lancet.
[33] R. Gelber,et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. , 1994, The New England journal of medicine.
[34] L. Kalish,et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child , 1996, The New England journal of medicine.
[35] H. Coovadia,et al. Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study , 1999, The Lancet.
[36] L. Mofenson,et al. A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006). , 1999, AIDS.
[37] J. Ward,et al. Trends in perinatal transmission of HIV/AIDS in the United States. , 1999, JAMA.
[38] J. Karon,et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial , 1999, The Lancet.
[39] Q. Karim. Global Strategies for the Prevention of HIV Transmission from Mothers to Infants , 2000, Annals of the New York Academy of Sciences.
[40] L. Hooper,et al. Recent HIV seroprevalence levels by country: February 1999. , 1997 .
[41] F. Dabis,et al. Prevention of mother-to-child transmission of HIV in Africa: uptake of pregnant women in a clinical trial in Abidjan, Côte d'Ivoire. , 1998, AIDS.
[42] S. Wiktor,et al. Prevention of mother-to-child transmission of HIV-1 in Africa. , 1997, AIDS.
[43] G. Duarte,et al. Mode of delivery and the risk of vertical transmission of HIV-1. , 1999, New England Journal of Medicine.
[44] M. Kalish,et al. Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group. , 1999, The Journal of infectious diseases.
[45] H. Minkoff,et al. The case for rapid HIV testing during labor. , 1998, JAMA.
[46] E. Karita,et al. Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. , 1991, Disease markers.
[47] A. Nicoll,et al. Infant feeding policy and practice in the presence of HIV-1 infection. , 1995, AIDS.
[48] Philippe Van de Perre,et al. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection , 1998, The Lancet.
[49] W. Graham,et al. Seizing the opportunity: collaborative initiatives to reduce HIV and maternal mortality , 1999, The Lancet.
[50] H. Varmus,et al. Ethical complexities of conducting research in developing countries. , 1997, The New England journal of medicine.
[51] Families,et al. Reducing the Odds: Preventing Perinatal Transmission of HIV In The United States , 1999 .